Cognipride MV 1mg/500mg/0.3mg Tablet
Marketer
Cognitive Life Sciences Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Cognipride MV 1mg/500mg/0.3mg Tablet
Diabetic medication, Glucotrim MD (1mg/500mg/0.3mg), combines multiple agents to manage type 2 diabetes in adults. This formulation assists in regulating blood glucose. Administer Glucotrim MD with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Glucotrim MD is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment. Consult your physician prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your doctor, are essential.
Uses of Cognipride MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Cognipride MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Cognipride MV 1mg/500mg/0.3mg Tablet on an empty stomach.
Common Side effects of Cognipride MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Cognipride MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cognipride MV 1mg/500mg/0.3mg Tablet on an empty stomach.
How Cognipride MV 1mg/500mg/0.3mg Tablet works:
Each Cognipride MV tablet (1mg/500mg/0.3mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Cognipride MV 1mg/500mg/0.3mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Cognipride MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Cognipride MV 1mg/500mg/0.3mg tablets is likely unsafe. Available data from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Cognipride MV 1mg/500mg/0.3mg Tablets in individuals with kidney impairment poses a likely safety risk and is best avoided. Medical advice is recommended. Furthermore, its use is discouraged for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Cognipride MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, initiating treatment with a low dose of Cognipride MV 1mg/500mg/0.3mg tablets is typical; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Cognipride MV 1mg/500mg/0.3mg Tablet :
Should you forget a Cognipride MV 1mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cognipride MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently